QIAGEN reports Q3 2026 revenue up 2.8% to $548M, suspends guidance amid EQT offer

QIAGEN NV reported Q3 2026 revenue up 2.8% to $548 million, above its prior outlook, with adjusted diluted EPS of $0.65 versus $0.61 a year earlier and GAAP EPS of $0.51. The company suspended its 2026 guidance due to the pending EQT Private Equity acquisition offer of €46.50 per share.

Detected & updated continuously · Source: Nebula